Delivery Order SPE2DB22D9112-SPE2DB23FE6UA
Award Date 6/28/23
Potential Completion Date 7/20/23
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DOD) awarded a $77,370 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. As the DLA supports the logistical needs of the military services, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness programs over the three week period of...
- The Defense Logistics Agency (DOD) awarded a $11,605.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML" under contract number 4560195210. Performance will take place in Park Ridge, Illinois over a period of approximately three weeks from March 6th through March 27th, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by providing supplies in...
- The Defense Logistics Agency awarded a $6,189.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois, with work scheduled to be completed between June 28, 2023 and July 20, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order was likely placed to supply the product to DOD customers and...
- The Defense Logistics Agency (DOD) awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is July 25, 2023 through August 15, 2023. No set aside designation or subcontractors were identified. The DLA supports the Department of Defense by providing supplies in support of readiness and contingency operations. This delivery...
- The Defense Logistics Agency (DOD) awarded a $8,123.85 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 26, 2023 through August 16, 2023. As the DLA supports the logistical needs of the military services, this contract for syringes of the medication Xolair is likely to support treatment of allergic or inflammatory conditions...
- The Defense Logistics Agency (DOD) awarded a $4,642.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The start date is July 6, 2023 and the end date is July 27, 2023. No set aside designation or subcontractors are indicated. The DLA procures and provides logistics support for medical supplies and equipment for the Department of Defense and other federal agencies, so this order is likely...
- The Defense Logistics Agency (DOD) awarded a $5,415.90 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 25, 2023 through August 15, 2023. No set aside designation or subcontractors were identified. The DLA supports the Department of Defense by providing supplies in support of readiness and contingency operations. This delivery...
- The Defense Logistics Agency (DOD) awarded a $10,831.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML" under contract number 4561680388. Performance will take place in Park Ridge, Illinois over a three week period concluding on August 18, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the U.S. military and other government agencies, this delivery order is likely fulfilling requirements...
- The Defense Logistics Agency (DOD) awarded a $8,527 delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The firm fixed price order is being carried out under the prime contractor DMS Pharmaceutical Group Inc. in Park Ridge, Illinois, running from September 29, 2023 through October 23, 2023. No set aside designation or subcontractors were indicated. The DLA supports military readiness by procuring and providing logistics support for medical...
- The Defense Logistics Agency, a component of the Department of Defense, awarded a $37,137.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The contract period runs from September 1, 2023 through September 25, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing logistics support and supplies in support of various DOD...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB23FE6UADelivery Order
The Defense Logistics Agency (DOD) awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from June 28, 2023 through July 20, 2023. As the DLA supports the logistical needs of the military services, this contract will likely deliver the pharmaceutical product to DOD medical treatment facilities and personnel within the specified timeframe to support patient care. No set aside designation or subcontractors were identified in the award information provided.
Generated 12/18/23, 8:22 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 6/28/23 |